Get Level 2

If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Fusion Antibodies Share Price
  4. Fusion Antibodies Share Regulatory News
  5. Notice of Interim Results

Pin to quick picksFusion Antibodies Regulatory News (FAB)

Fusion Antibodies Information

Share Price Information for Fusion Antibodies (FAB)

Share Price is delayed by 15 minutes
Get Live Data
12.00    0.50 (4.35%)
Bid:
11.50
Ask:
12.50
Spread: 1.00 (8.696%)
Market Cap: £15.02m
FAB Live PriceLast checked at - London Stock Exchange

Intraday Fusion Antibodies Share Chart

Notice of Interim Results

24 Sep 2008 07:00

RNS Number : 1109E
Fabian Romania Limited
24 September 2008
 

24 September 2008

Fabian Romania Limited

Notice of Interim Results

On Monday 29 September 2008 Fabian Romania Limited, the AIM listed dedicated Romanian real estate company, will announce its interim results for the six months ended 30 June 2008.

Enquiries

Fabian Capital Limited (investment manager to the company)

Anthony Foster 020 7499 9988

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORSEWFLDSASEEU
1234567
Date   Source Headline
1st Jul 20264:45 pmRNSHolding(s) in Company
30th Jun 20265:00 pmRNSTotal Voting Rights
22nd Jun 20267:00 amRNSNotice of allowance of patent in Canada
15th Jun 20267:00 amRNSUpdate on grant-funded DR5 project
2nd Jun 20267:00 amRNSExercise of options and total voting rights
11th May 20263:06 pmRNSHolding(s) in Company
11th May 202611:05 amRNSGrant of patent in Japan
5th May 20267:00 amRNSYear-end trading statement
30th Mar 20267:00 amRNSAntibody IP transfer agreement
17th Feb 202611:42 amRNSDirector/PDMR Shareholding
4th Feb 20263:27 pmRNSHolding(s) in Company
2nd Feb 202611:33 amRNSHolding(s) in Company
30th Jan 20265:00 pmRNSTotal Voting Rights
27th Jan 20267:05 amRNSIssue of Director Shares
27th Jan 20267:00 amRNSPlacing and Subscription to raise approx £1.4m
19th Dec 20257:00 amRNSUpdate on negotiations with NCI regarding OptiMAL
19th Dec 20257:00 amRNSUpdate on negotiations with NCI regarding OptiMAL
16th Dec 202511:04 amRNSLaunch of OptiMAL platform
11th Dec 20257:00 amRNS-RMammalian Display video
25th Nov 202512:11 pmRNSHolding(s) in Company
24th Nov 20257:00 amRNSHalf-year Financial Report
21st Nov 20257:00 amRNSNotice of Results
13th Nov 20257:00 amRNS-ROptiMAL Library video
3rd Nov 20257:00 amRNSOptiMAL® R&D Update
27th Oct 20253:38 pmRNSHolding(s) in Company
16th Oct 20251:31 pmRNSResult of AGM
16th Oct 20257:00 amRNSAGM statement and H1 trading update
8th Oct 20257:00 amRNSContract win
19th Sep 202512:58 pmRNSPosting of Annual Report & Notice of AGM
17th Sep 20257:00 amRNSOptiMAL R&D Update
8th Sep 20257:00 amRNS-RBelfast investor presentation
4th Sep 20257:00 amRNSFinal Results
28th Aug 20257:00 amRNSContract Win
27th Aug 20257:00 amRNSContract wins with existing client
26th Aug 20257:00 amRNS-RInvestor presentations
5th Aug 20257:00 amRNSGrant of U.S. Patent for OptiMAL
24th Jul 202510:56 amRNSIssue Notification: US Patent Update
11th Jul 20257:00 amRNSDirector/PDMR Shareholding
2nd Jun 20257:00 amRNSTotal Voting Rights
22nd May 20252:33 pmRNSUpdate on U.S. Patent for OptiMAL®
8th May 20257:00 amRNS-RInvestor presentation
7th May 20257:00 amRNSIssue of shares to non-executive directors
6th May 202510:53 amRNSDirector/PDMR Shareholding
6th May 202510:38 amRNSHolding(s) in Company
6th May 20257:00 amRNSTrading update
30th Apr 20255:00 pmRNSTotal Voting Rights
24th Apr 20257:00 amRNSApproval of grant funding
11th Apr 202510:40 amRNSHolding(s) in Company
10th Apr 202512:47 pmRNSHolding(s) in Company
7th Apr 202512:35 pmRNSResult of General Meeting
1234567

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
NAIT
North American
LSE
0.23%
TATE
Tate & Lyle
LSE
-0.18%
BBH
Bellevue Health
LSE
-2.40%
AML
Aston Martin Lagonda
LSE
-1.56%
TRG
TRG.L
LSE
0.00%
Trending
GGP
Greatland Resources
LSE
0.17%
SAGA
Saga
LSE
2.48%
OPTI
OptiBiotix Health
LSE
0.00%
ASTR.PL
Astrid Intelligence Plc
AQSE
-8.82%
CBG
Close Bros
LSE
-1.92%